Your browser doesn't support javascript.
loading
Extracellular vesicles: a rising star for therapeutics and drug delivery.
Du, Shuang; Guan, Yucheng; Xie, Aihua; Yan, Zhao; Gao, Sijia; Li, Weirong; Rao, Lang; Chen, Xiaojia; Chen, Tongkai.
Affiliation
  • Du S; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, 12 Jichang Road, Guangzhou, 510405, China.
  • Guan Y; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, 12 Jichang Road, Guangzhou, 510405, China.
  • Xie A; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, 12 Jichang Road, Guangzhou, 510405, China.
  • Yan Z; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, 12 Jichang Road, Guangzhou, 510405, China.
  • Gao S; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Room 6007, N22, Taipa, 999078, Macau SAR, China.
  • Li W; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, 12 Jichang Road, Guangzhou, 510405, China.
  • Rao L; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China. lrao@szbl.ac.cn.
  • Chen X; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Room 6007, N22, Taipa, 999078, Macau SAR, China. xiaojiachen@um.edu.mo.
  • Chen T; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, 12 Jichang Road, Guangzhou, 510405, China. chentongkai@gzucm.edu.cn.
J Nanobiotechnology ; 21(1): 231, 2023 Jul 20.
Article in En | MEDLINE | ID: mdl-37475025
Extracellular vesicles (EVs) are nano-sized, natural, cell-derived vesicles that contain the same nucleic acids, proteins, and lipids as their source cells. Thus, they can serve as natural carriers for therapeutic agents and drugs, and have many advantages over conventional nanocarriers, including their low immunogenicity, good biocompatibility, natural blood-brain barrier penetration, and capacity for gene delivery. This review first introduces the classification of EVs and then discusses several currently popular methods for isolating and purifying EVs, EVs-mediated drug delivery, and the functionalization of EVs as carriers. Thereby, it provides new avenues for the development of EVs-based therapeutic strategies in different fields of medicine. Finally, it highlights some challenges and future perspectives with regard to the clinical application of EVs.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / Extracellular Vesicles Language: En Journal: J Nanobiotechnology Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / Extracellular Vesicles Language: En Journal: J Nanobiotechnology Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido